Vonoprazan-associated long QT syndrome.

Kimitoshi KuboToru SakakibaraKazuya YonezawaMototsugu Kato

Published in: Journal of general and family medicine (2021)

To our knowledge, this is the first report describing a case of vonoprazan-associated QT prolongation newly occurring after initiation of the drug and improving after its discontinuation in a patient concurrently receiving polypharmacy including a drug metabolized by CYP3A4.

Keyphrases

drug induced
helicobacter pylori
adverse drug
case report
endoscopic submucosal dissection
healthcare
gastroesophageal reflux disease